Company Filing History:
Years Active: 2011-2019
Title: Henning Vollert: Innovator in Pharmaceutical Science
Introduction
Henning Vollert is a notable inventor based in Bad Segeberg, Germany. He has made significant contributions to the field of pharmaceutical science, particularly in the development of innovative treatments for various health disorders. With a total of 2 patents, his work focuses on addressing critical medical challenges.
Latest Patents
Vollert's latest patents include a composition for the treatment of hyperglycaemic disorders. This invention involves a synergistic composition that comprises phlorizin and at least one further defined inhibitor of the enzyme lactase-phlorizin hydrolase. The composition is aimed at treating or preventing hyperglycemic diseases such as obesity and diabetes. Additionally, he has developed di(hetero)arylcyclohexane derivatives, which are valuable pharmaceutical active compounds. These compounds inhibit ATP-sensitive potassium channels in the heart muscle and are suitable for treating cardiovascular disorders, including arrhythmias and cardiac insufficiency.
Career Highlights
Throughout his career, Henning Vollert has worked with prominent companies in the pharmaceutical industry. Notable among these are Bioactive Food GmbH and Sanofi-Aventis. His experience in these organizations has contributed to his expertise in developing innovative pharmaceutical solutions.
Collaborations
Vollert has collaborated with several professionals in his field, including Thomas Bohme and Uwe Gerlach. These collaborations have further enhanced his research and development efforts.
Conclusion
Henning Vollert is a distinguished inventor whose work in pharmaceutical science has led to significant advancements in the treatment of various health conditions. His innovative patents reflect his commitment to improving patient care and addressing critical medical needs.